Session: Enabling Technologies Relevant to Drug Substance

This session invites submissions on enabling technologies (i.e., equipment, methodology or capability that provides the means to increase capacity, performance, robustness for patients, products, or processes ). This session focuses on enabling technologies that support the design, development, and manufacturing of drug substances, drug products, and combination products. Contributions showcasing innovations in processing, device design, measurement technologies, modeling, and automation that enhance pharmaceutical development are highly encouraged. Submissions are also welcome on delivery or diagnostic devices specifically developed in response to global public health challenges. Key areas of interest include, but are not limited to: •Novel processing equipment for improved efficiency and scalability. •Adaptation of existing technologies to support emerging modalities. •Advancements in device design that enhance drug delivery and diagnostics. •Measurement technologies that enable new or improved process control. •Modeling and simulation approaches to support enabling technologies •High-throughput experimentation (HTE), process analytical technology (PAT), and automation to accelerate process development and ensure quality. This session aims to highlight cutting-edge approaches that drive innovation and efficiency in pharmaceutical development and manufacturing.